Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Drug & Medical Device & Aesthetics, 肌顏態 was displayed at the CSD2025, The GeneQueens and 金因敷 launch was grandly held in Changsha
Drug & Medical Device & Aesthetics, 肌顏態 was displayed at the CSD2025, The GeneQueens and 金因敷 launch was grandly held in Changsha
Drug & Medical Device & Aesthetics, 肌顏態 was displayed at the CSD2025, The GeneQueens and 金因敷 launch was grandly held in Changsha
Chief Legal and Admin Officer of Pathward Financial Sells Nearly Half Her Stock Holding: https://g.foolcdn.com/misc-assets/insider.png
Chief Legal and Admin Officer of Pathward Financial Sells Nearly Half Her Stock Holding

On October 24, 2025, Nadia Dombrowski, Chief Legal and Admin Officer at Pathward Financial (NASDAQ:CASH), disclosed in a SEC Form 4 filing the open-market sale of 5,000 shares, for a transaction

Uni-Bio Science Group Embarks on New Strategy and Launches New Website, Advancing Towards Becoming a Global Leader in Regenerative Medicine
Uni-Bio Science Group Embarks on New Strategy and Launches New Website, Advancing Towards Becoming a Global Leader in Regenerative Medicine
Uni-Bio Science Group Embarks on New Strategy and Launches New Website, Advancing Towards Becoming a Global Leader in Regenerative Medicine
Trio Group and Bayambang City in the Philippines Have Reached Agreement to Cooperate on New Energy Projects
Trio Group and Bayambang City in the Philippines Have Reached Agreement to Cooperate on New Energy Projects
Trio Group and Bayambang City in the Philippines Have Reached Agreement to Cooperate on New Energy Projects
Uni-Bio Science Group and Kexing Biopharm Forge Strategic Partnership to Accelerate Global Expansion of Osteoporosis Treatment Bogutai®
Uni-Bio Science Group and Kexing Biopharm Forge Strategic Partnership to Accelerate Global Expansion of Osteoporosis Treatment Bogutai®
Uni-Bio Science Group and Kexing Biopharm Forge Strategic Partnership to Accelerate Global Expansion of Osteoporosis Treatment Bogutai®
Uni-Bio Science Group Announces 2025 Interim Results
Uni-Bio Science Group Announces 2025 Interim Results
Uni-Bio Science Group Announces 2025 Interim Results
Hong Kong Ferry announces FY2025 interim results Revenue decreases by 5%
Hong Kong Ferry announces FY2025 interim results Revenue decreases by 5%
Hong Kong Ferry announces FY2025 interim results Revenue decreases by 5%
HONG KONG FERRY GROUP COLLABORATES WITH TUNG WAH GROUP OF HOSPITALS  TO LAUNCH YOUTH HOSTEL PROJECT TO GENERATE STABLE RENTAL INCOME
HONG KONG FERRY GROUP COLLABORATES WITH TUNG WAH GROUP OF HOSPITALS TO LAUNCH YOUTH HOSTEL PROJECT TO GENERATE STABLE RENTAL INCOME
HONG KONG FERRY GROUP COLLABORATES WITH TUNG WAH GROUP OF HOSPITALS TO LAUNCH YOUTH HOSTEL PROJECT TO GENERATE STABLE RENTAL INCOME
Uni-Bio Science Group Receives NMPA Approval for 金因康® (Diquafosol Sodium Eye Drops), Advancing Dry Eye Syndrome Treatment in China
Uni-Bio Science Group Receives NMPA Approval for 金因康® (Diquafosol Sodium Eye Drops), Advancing Dry Eye Syndrome Treatment in China
Uni-Bio Science Group Receives NMPA Approval for 金因康® (Diquafosol Sodium Eye Drops), Advancing Dry Eye Syndrome Treatment in China
Uni-Bio Science Group Limited Announces 2024 Annual Results
Uni-Bio Science Group Limited Announces 2024 Annual Results
Uni-Bio Science Group Limited Announces 2024 Annual Results
Hong Kong Ferry (0050.HK) announces FY2024 annual results
Hong Kong Ferry (0050.HK) announces FY2024 annual results
Hong Kong Ferry (0050.HK) announces FY2024 annual results